Nagi & MolGen in tandem at the European Worm Meeting 2022 at booth #5
Exploring the advantages of microfluidic chips for biological experiments.
The quest for efficiency does not distinguish between industries. And labs are no exception. But, what does it implies to automate your lab?
Our CEO and co-founder, Matteo Cornaglia, speaks today about the future of New Approach Methodologies and how Nagi Bioscience is fulfilling this market need in an interview for Verve Ventures.
The US House of Representatives passed the FDA Modernization Act to transform the drug approval process and move towards a non-animal testing future.
Meet the Organism-on-Chip that is revolutionizing the biotech sector in Nagi’s booth at Future Labs Live in Basel.
Radio Télévision Suisse consulted our co-founder and CSO Laurent Mouchiroud about today’s advances in the field of aging and longevity research for the monthly health reportage.
From drug discovery to a possible future tool for lung cancer detection. How the Worm-on-chip is revolutionizing the alternative testing methods sector.
How a tiny worm is helping to reveal the mystery of human tumors’ formation and the development of cancer drug candidates.
From the 3Rs model created in 1959 to today’s animal welfare acts